Gino Santini - Jun 3, 2021 Form 4 Insider Report for Allena Pharmaceuticals, Inc. (ALNAQ)

Role
Director
Signature
/s/ Kevin Brennan, attorney-in-fact
Stock symbol
ALNAQ
Transactions as of
Jun 3, 2021
Transactions value $
$0
Form type
4
Date filed
6/4/2021, 04:00 PM
Previous filing
Jun 1, 2021
Next filing
May 2, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALNAQ Stock Option (Right to Buy) Award $0 +37K $0.00 37K Jun 3, 2021 Common Stock 37K $1.14 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock option shall vest in full (i.e., in single installment) upon the earlier to occur of the first anniversary of the date of grant or the date of the next annual meeting of stockholders.